Given NRF2's crucial role in driving NSCLC tumorigenesis, metastasis, and drug resistance, our results also confirmed that NRF2 maintains a higher expression level in NSCLC cell lines than in normal lung epithelial cells (Fig. 6B). Here, NFE2L2 is linked to non-small cell lung carcinoma.